upadacitinib
abbvie
['upadacitinib']
impressive deltas from placebo in #upadacitinib in #ulcerativecolitis #ueg22 #somosgeteccu no real new safety signals in &gt;600 patients and 52 weeks of follow-up. we will have a real good new drug for #ulcerativecolitis 
Medicine, Inflammatory Bowel Disease, Beethoven, Life. #GETECCU, #EII #Crohn #CU #AEGASTRO #ECCO #AGA